Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

Bibliographic Details
Main Authors:	Alexopoulos, Panagiotis, Werle, Lukas, Roesler, Jennifer, Thierjung, Nathalie, Gleixner, Lena Sophie, Yakushev, Igor, Laskaris, Nikolaos, Wagenpfeil, Stefan, Gourzis, Philippos, Kurz, Alexander, Perneczky, Robert
Format:	Online
Language:	English
Published:	BioMed Central 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146856/

Similar Items

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
by: Grimmer, Timo, et al.
Published: (2012)

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease
by: Perneczky, R, et al.
Published: (2013)

Pulmonary Embolism Related to Amisulpride Treatment: A Case Report
by: Skokou, Maria, et al.
Published: (2013)

Frontotemporal Dementia, Manifested as Schizophrenia, with Decreased Heterochromatin on Chromosome 1
by: Gourzis, Philippos, et al.
Published: (2012)

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease
by: Li, Rui, et al.
Published: (2015)

Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric Populations
by: Skokou, Maria, et al.
Published: (2012)

ETHICAL ASECTS OF OVERCOMING CLASSICAL ARMED CONFLICTS’ CONSEQUENCES
by: L V Yakushev
Published: (2017-12-01)

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
by: Mehrabian, Shima, et al.
Published: (2015)

Depressive symptoms in late life in urban and semi-urban areas of South-West Greece: An undetected disorder?
by: Argyropoulos, Konstantinos, et al.
Published: (2015)

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia
by: Spitzer, Philipp, et al.
Published: (2011)

Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
by: Maetzler, Walter, et al.
Published: (2012)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
by: Bibl, Mirko, et al.
Published: (2012)

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
by: Landqvist Waldö, Maria, et al.
Published: (2013)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
by: Nakayama, Yui, et al.
Published: (2013)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
by: Sweeney, Melanie D, et al.
Published: (2015)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
by: Bloniecki, Victor, et al.
Published: (2014)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
by: Forlenza, Orestes V., et al.
Published: (2015)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
by: Hansson, Oskar, et al.
Published: (2014)

Kynurenic Acid Levels in Cerebrospinal Fluid from Patients with Alzheimer’s Disease or Dementia with Lewy Bodies
by: Wennström, Malin, et al.
Published: (2014)

LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo
by: Grimmer, Timo, et al.
Published: (2014)

Spontaneous Up states in vitro: a single-metric index of the functional maturation and regional differentiation of the cerebral cortex
by: Rigas, Pavlos, et al.
Published: (2015)

Greater Repertoire and Temporal Variability of Cross-Frequency Coupling (CFC) Modes in Resting-State Neuromagnetic Recordings among Children with Reading Difficulties
by: Dimitriadis, Stavros I., et al.
Published: (2016)

Book Review: Ancient medicine
by: Laskaris, Julie
Published: (2006)

Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia – case report
by: Andersson, Lars-Magnus, et al.
Published: (2006)

Validation of a prefractionation method followed by two-dimensional electrophoresis – Applied to cerebrospinal fluid proteins from frontotemporal dementia patients
by: Hansson, Sara Folkesson, et al.
Published: (2004)

Alzheimer's Disease Dementia as the Diagnosis Best Supported by the Cerebrospinal Fluid Biomarkers: Difference in Cut-Off Levels from Thai Experience
by: Senanarong, V., et al.
Published: (2012)

Elevated BAFF Levels in the Cerebrospinal Fluid of Patients with Neuro-Behçet's Disease: BAFF is Correlated with Progressive Dementia and Psychosis
by: Sumita, Y, et al.
Published: (2012)

Cerebrospinal fluid biomarkers in Alzheimer’s disease, vascular dementia and ischemic stroke patients: a critical analysis
by: Kaerst, Lisa, et al.
Published: (2013)

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia
by: Ananya Chakraborty, et al.
Published: (2018-06-01)

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
by: Ione O. C. Woollacott, et al.
Published: (2018-08-01)

Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis
by: Struyfs, Hanne, et al.
Published: (2015)

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
by: Wennström, Malin, et al.
Published: (2015)

Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?
by: Weston, Philip S.J., et al.
Published: (2016)

GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia
by: Maetzler, Walter, et al.
Published: (2016)

miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study
by: Sørensen, Sofie Sølvsten, et al.
Published: (2016)

Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia
by: Fujita, Koji, et al.
Published: (2013)

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics
by: Teunissen, Charlotte E., et al.
Published: (2016)

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes
by: Pijnenburg, Yolande A.L., et al.
Published: (2015)

Reference Cluster Normalization Improves Detection of Frontotemporal Lobar Degeneration by Means of FDG-PET
by: Dukart, Juergen, et al.
Published: (2013)

Possible role of the cavernous sinus veins in cerebrospinal fluid absorption
by: Johnston, Miles, et al.
Published: (2007)